{"title":"네이버 금융 ─ 뉴스 ─ 실시간 속보","url":"https://finance.naver.com/news/news_list.naver?mode=LSS2D&section_id=101&section_id2=258","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"[공시] 한국석유공업 3·4분기 영업이익 21억원···전년比 55%↓","contents":"<a href=\"/news/news_read.naver?article_id=0004731152&amp;office_id=014&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211029&amp;page=1\" title=\"[공시] 한국석유공업 3·4분기 영업이익 21억원···전년比 55%↓\">[공시] 한국석유공업 3·4분기 영업이익 21억원···전년比 55%↓</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004731152&office_id=014&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211029&page=1","retrieved":1635480331525},{"title":"SK머티리얼즈, SK㈜에 흡수합병…임시 주총서 의결","contents":"<a href=\"/news/news_read.naver?article_id=0012756090&amp;office_id=001&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211029&amp;page=1\" title=\"SK머티리얼즈, SK㈜에 흡수합병…임시 주총서 의결\">SK머티리얼즈, SK㈜에 흡수합병…임시 주총서 의결</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0012756090&office_id=001&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211029&page=1","retrieved":1635480331526},{"title":"[공시] SKIET, 3·4분기 영업이익 416억원···전년比 41.02%↑","contents":"<a href=\"/news/news_read.naver?article_id=0004731151&amp;office_id=014&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211029&amp;page=1\" title=\"[공시] SKIET, 3·4분기 영업이익 416억원···전년比 41.02%↑\">[공시] SKIET, 3·4분기 영업이익 416억원···전년比 41.02%↑</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004731151&office_id=014&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211029&page=1","retrieved":1635480331527},{"title":"박기훈 SM상선 대표 “IPO 통해 2024년까지 노선 18개로 확대”","contents":"<a href=\"/news/news_read.naver?article_id=0002543086&amp;office_id=119&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211029&amp;page=1\" title=\"박기훈 SM상선 대표 “IPO 통해 2024년까지 노선 18개로 확대”\">박기훈 SM상선 대표 “IPO 통해 2024년까지 노선 18개로 확대”</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0002543086&office_id=119&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211029&page=1","retrieved":1635480331529},{"title":"SM상선, \"코스닥 상장 통해 노선 확대·환경규제 대응할 것\"","contents":"<a href=\"/news/news_read.naver?article_id=0004731147&amp;office_id=014&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211029&amp;page=1\" title=\"SM상선, &quot;코스닥 상장 통해 노선 확대·환경규제 대응할 것&quot;\">SM상선, \"코스닥 상장 통해 노선 확대·환경규제 대응할 것\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004731147&office_id=014&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211029&page=1","retrieved":1635480331530},{"title":"SK이노 \"배터리 수주물량 220조원 규모…내년 흑자전환 전망\"","contents":"<a href=\"/news/news_read.naver?article_id=0012756033&amp;office_id=001&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211029&amp;page=1\" title=\"SK이노 &quot;배터리 수주물량 220조원 규모…내년 흑자전환 전망&quot;\">SK이노 \"배터리 수주물량 220조원 규모…내년 흑자전환 전망\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0012756033&office_id=001&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211029&page=1","retrieved":1635480331531},{"title":"[마켓인]국민참여 뉴딜펀드 2차 출자사업 6개 운용사 선정","contents":"<a href=\"/news/news_read.naver?article_id=0005073276&amp;office_id=018&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211029&amp;page=1\" title=\"[마켓인]국민참여 뉴딜펀드 2차 출자사업 6개 운용사 선정\">[마켓인]국민참여 뉴딜펀드 2차 출자사업 6개 운용사 선정</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005073276&office_id=018&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211029&page=1","retrieved":1635480331532},{"title":"테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]","contents":"<a href=\"/news/news_read.naver?article_id=0004622292&amp;office_id=015&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211029&amp;page=1\" title=\"테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]\">테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004622292&office_id=015&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211029&page=1","retrieved":1635480331534}]}